RESUMEN
Linezolid is a promising antimicrobial agent for the treatment of multidrug-resistant tuberculosis (MDR-TB), but its use is limited by toxicity. Therapeutic drug monitoring (TDM) may help to minimize toxicity while adequate drug exposure is maintained. Conventional plasma sampling and monitoring might be hindered in many parts of the world by logistical problems that may be solved by dried blood spot (DBS) sampling. The aim of this study was to develop and validate a novel method for TDM of linezolid in MDR-TB patients using DBS sampling. Plasma, venous DBS, and capillary DBS specimens were obtained simultaneously from eight patients receiving linezolid. A DBS sampling method was developed and clinically validated by comparing DBS with plasma results using Passing-Bablok regression and Bland-Altman analysis. This study showed that DBS analysis was reproducible and robust. Accuracy and between- and within-day precision values from three validations presented as bias and coefficient of variation (CV) were less than 17.2% for the lower limit of quantification and less than 7.8% for other levels. The method showed a high recovery of approximately 95% and a low matrix effect of less than 8.7%. DBS specimens were stable at 37°C for 2 months and at 50°C for 1 week. The ratio of the concentration of linezolid in DBS samples to that in plasma was 1.2 (95% confidence interval [CI], 1.12 to 1.27). Linezolid exposure calculated from concentrations DBS samples and plasma showed good agreement. In conclusion, DBS analysis of linezolid is a promising tool to optimize linezolid treatment in MDR-TB patients. An easy sampling procedure and high sample stability may facilitate TDM, even in underdeveloped countries with limited resources and where conventional plasma sampling is not feasible.
Asunto(s)
Acetamidas/sangre , Antituberculosos/sangre , Monitoreo de Drogas/métodos , Mycobacterium tuberculosis/efectos de los fármacos , Oxazolidinonas/sangre , Tuberculosis Resistente a Múltiples Medicamentos/sangre , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Acetamidas/farmacocinética , Acetamidas/farmacología , Adulto , Antituberculosos/farmacocinética , Antituberculosos/farmacología , Cromatografía Líquida de Alta Presión , Pruebas con Sangre Seca , Femenino , Humanos , Linezolid , Masculino , Mycobacterium tuberculosis/crecimiento & desarrollo , Oxazolidinonas/farmacocinética , Oxazolidinonas/farmacología , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Espectrometría de Masas en Tándem , Tuberculosis Resistente a Múltiples Medicamentos/microbiologíaRESUMEN
BACKGROUND: Optimal drug dosing is important to ensure adequate response to treatment, prevent development of drug resistance and reduce drug toxicity. The aim of these clinical standards is to provide guidance on 'best practice´ for dosing and management of TB drugs.METHODS: A panel of 57 global experts in the fields of microbiology, pharmacology and TB care were identified; 51 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all participants.RESULTS: Six clinical standards were defined: Standard 1, defining the most appropriate initial dose for TB treatment; Standard 2, identifying patients who may be at risk of sub-optimal drug exposure; Standard 3, identifying patients at risk of developing drug-related toxicity and how best to manage this risk; Standard 4, identifying patients who can benefit from therapeutic drug monitoring (TDM); Standard 5, highlighting education and counselling that should be provided to people initiating TB treatment; and Standard 6, providing essential education for healthcare professionals. In addition, consensus research priorities were identified.CONCLUSION: This is the first consensus-based Clinical Standards for the dosing and management of TB drugs to guide clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment to improve patient care.
Asunto(s)
Antituberculosos , Monitoreo de Drogas , Tuberculosis , Humanos , Atención al Paciente , Estándares de Referencia , Tuberculosis/tratamiento farmacológico , Antituberculosos/administración & dosificaciónRESUMEN
INTRODUCTION: Few innovative anti-microbial products have been brought to market in recent years to combat the global multidrug resistant-tuberculosis (MDR-TB) epidemic. Bedaquiline, a novel oral diarylquinoline, was approved by the US FDA as a part of combination therapy in adults with pulmonary MDR-TB based on phase II trials. AREA COVERED: Pubmed searches were conducted using search terms bedaquiline, diarylquinoline, R207910, and TMC207 was performed. Supplementary sources included World Health Organization, Clinicaltrial.gov, US Food and Drug Administration. Bedaquiline is an ATP synthase inhibitor specific for M. tuberculosis and some nontuberculous mycobacteria. It is metabolized by CYP3A4 and it's drug exposure can be influenced by inducers and inhibitors of this enzyme. Phase II studies showed promising results on efficacy of bedaquiline when being used in combination with a background regimen for MDR-TB. Main safety concerns include QTc prolongation and hepatotoxicity. Phase III trials are ongoing to confirm efficacy findings from phase II studies and provide additional evidence of safety and efficacy. Expert commentary: Critical data for long-term efficacy and safety are incomplete and scarce, supporting the cautious use of bedaquiline.
Asunto(s)
Diarilquinolinas/uso terapéutico , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Pulmonar/tratamiento farmacológico , Administración Oral , Adulto , Animales , Antituberculosos/administración & dosificación , Antituberculosos/efectos adversos , Antituberculosos/uso terapéutico , Citocromo P-450 CYP3A/efectos de los fármacos , Citocromo P-450 CYP3A/metabolismo , Diarilquinolinas/administración & dosificación , Diarilquinolinas/efectos adversos , Interacciones Farmacológicas , Quimioterapia Combinada , Humanos , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/aislamiento & purificación , Tuberculosis Resistente a Múltiples Medicamentos/microbiología , Tuberculosis Pulmonar/microbiologíaRESUMEN
The changes in distribution and density of the serotoninergic innervation of the cerebral cortex were studied in kittens from birth (PO) to 60 days of age (P59). Three cortical areas were sampled: prefrontal, primary auditory, and primary visual areas. Two systems of serotoninergic axons were demonstrated by immunocytochemical techniques: the fine axon system characterized by small fusiform varicosities up to 1 micron in diameter, and the beaded axon system, the fibers of which have round varicosities up to 5 microns in diameter. The density of the two types of fibers across the cortical layers at different ages was measured with a semiautomatic computerized system. In all three areas, the density of fine axons increased steadily from birth, although the pattern of innervation changed from an even distribution at PO to a distinct concentration of the fibers in layers I-III by week 2 in the prefrontal cortex and by week 3 in auditory and visual cortices. By contrast, the beaded axons first appeared in the cortex at week 2 for the prefrontal cortex, at week 3 in auditory and visual areas. Initially, these fibers were distributed throughout all cortical layers and were of much lower density than the fine axons. At later ages the beaded axons became confined to layers I-III where they gradually increased in number, and from week 4, they formed pericellular arrays which were only observed in the prefrontal and auditory cortices, not in visual cortex. These findings provide further evidence for the existence of two parallel subsystems of serotoninergic axons which are different not only in their morphology and nuclear origin, but also in their development. Our finding that the two serotoninergic fiber systems arrive in the cortex in two different stages suggests that they have differential roles in development. The late formation of the pericellular arrays indicates that the formation of the specific connections made by the beaded fibers could be dependent on a certain degree of maturity of the target neurons.
Asunto(s)
Gatos/crecimiento & desarrollo , Corteza Cerebral/crecimiento & desarrollo , Serotonina , Vías Aferentes/anatomía & histología , Animales , Animales Recién Nacidos , Corteza Auditiva/anatomía & histología , Corteza Auditiva/química , Corteza Auditiva/crecimiento & desarrollo , Axones/ultraestructura , Mapeo Encefálico , Gatos/anatomía & histología , Recuento de Células , Corteza Cerebral/anatomía & histología , Corteza Cerebral/química , Núcleos del Rafe/anatomía & histología , Serotonina/análisis , Serotonina/fisiología , Corteza Visual/anatomía & histología , Corteza Visual/química , Corteza Visual/crecimiento & desarrolloRESUMEN
Collection of peripheral stem cells by apheresis is a well-described process. Here, investigations concerning 'agglutination and flocculation' of stem cells collected from two patients are described. In both cases, cryoproteins were observed and cryofibrinogen was identified using high-resolution two-dimensional electrophoresis. In one case, peripheral stem cells were collected after a second course of mobilization, and the cells were immediately washed at 37 degrees C before being frozen, allowing their use, despite the presence of cryofibrinogen. In the other case, 'agglutination' was reversed by warming the bag, and plasma was removed before freezing.
Asunto(s)
Aglutinación , Eliminación de Componentes Sanguíneos , Crioglobulinas/farmacología , Fibrinógenos Anormales/farmacología , Células Madre Hematopoyéticas/efectos de los fármacos , Aglutinación/efectos de los fármacos , Adhesión Celular/efectos de los fármacos , Crioglobulinas/aislamiento & purificación , Criopreservación , Electroforesis en Gel Bidimensional , Fibrinógenos Anormales/aislamiento & purificación , Floculación , Trasplante de Células Madre Hematopoyéticas , Células Madre Hematopoyéticas/citología , Humanos , Masculino , Persona de Mediana Edad , Trasplante AutólogoRESUMEN
INTRODUCTION: Rifampicin (RIF) and clarithromycin (CLR) are common drugs for the treatment of infections like Mycobacterium tuberculosis and Mycobacterium ulcerans. Treatment for these diseases are long-term and the individual pharmacokinetic variation, drug-drug interactions or non-adherence may introduce sub-therapeutic exposure or toxicity. The application of therapeutic drug monitoring (TDM) can be used to ensure efficacy and avoid toxicity. With the use of dried blood spot (DBS), TDM may be feasible in rural areas. During DBS method development, unexpected interactions or matrix effects may be encountered due to endogenous components in the blood. Another complication compared to plasma analysis is that RIF can form chelate complexes with ferric ions or can bind with hemes, which are potentially present in the extracts of dried blood spots. METHODS: The investigation focused on the interaction between RIF and the endogenous components of the DBS. The use of ethylenediaminetetraacetic acid (EDTA) and deferoxamine (DFX) as chelator agents to improve recoveries and matrix effects were investigated. A rapid analytical method was developed and validated to quantify RIF and CLR and their active metabolites desacetyl rifampicin (DAc-RIF) and 14-hydroxyclarythromcin (14OH-CLR) in DBS samples. A clinical application study was performed in tuberculosis patients by comparing DBS concentrations with plasma concentrations. RESULTS: The interaction between RIF and the DBS matrix was avoided using the complexing agents EDTA and DFX, which improved recoveries and matrix effects. The developed sample procedure resulted in a simple and fast method for the simultaneous quantification of RIF, CLR and their metabolites in DBS samples. High stability was observed as all four substances were stable at ambient temperature for 2 months. Deming regression analysis of the clinical application study showed no significant differences for RIF, DAc-RIF, CLR and 14OH-CLR between patient plasma and DBS analysis. The slopes of the correlation lines between DBS and plasma concentrations of RIF, DAc-RIF, CLR and 14OH-CLR were 0.90, 0.99, 0.80 and 1.09 respectively. High correlations between plasma and DBS concentrations were observed for RIF (R(2)=0.9076), CLR (R(2)=0.9752) and 14OH-CLR (R(2)=0.9421). Lower correlation was found for DAc-RIF (R(2) of 0.6856). CONCLUSION: The validated method is applicable for TDM of RIF, CLR and their active metabolites. The stability of the DBS at high temperatures can facilitate the TDM and pharmacokinetic studies of RIF and CLR even in resource limited areas. The role of EDTA and DFX as complexing agents in the extraction was well investigated and may provide a solution for potential applications to other DBS analytical methods.
Asunto(s)
Cromatografía Liquida/métodos , Claritromicina/sangre , Rifampin/sangre , Espectrometría de Masas en Tándem/métodos , Reproducibilidad de los ResultadosRESUMEN
Clarithromycin and rifampicin are used for the treatment of Mycobacteria. Pharmacokinetic drug interaction is possibly due to the influence of the two drugs on the liver enzymes. Using a Hypurity Aquastar C18 column (50mm×2.1mm×5µm) for liquid chromatography including a polar end-capped phase for the determination of clarithromycin, rifampicin and their metabolites together in plasma using LC-MS/MS resulted in a substantial carry-over. As a consequence, the throughput of the method is not assured. Using a step-by-step troubleshooting procedure, such carry-over was found originating from column memory effect. With the use of another type of C18 column, the carry-over is eliminated. Due to the absence of carry-over, the analytical concentration ranges are extended and are therefore more appropriate for the analysis of patient samples. The method was re-validated for linearity, reproducibility and dilution integrity.
Asunto(s)
Cromatografía Liquida/métodos , Claritromicina/sangre , Rifampin/sangre , Espectrometría de Masas en Tándem/métodos , Claritromicina/análogos & derivados , Claritromicina/química , Claritromicina/metabolismo , Humanos , Modelos Lineales , Reproducibilidad de los Resultados , Rifampin/análogos & derivados , Rifampin/química , Rifampin/metabolismo , Sensibilidad y EspecificidadRESUMEN
SETTINGS: Private pharmacies in Hanoi, Viet Nam. OBJECTIVES: To explore the response of health care providers (HCPs) in private pharmacies to suspected tuberculosis (TB) patients. METHODS: A simulated patient method combined with an interview in 128 randomly selected private pharmacies and 10 private pharmacies near TB hospitals. RESULTS: In the simulated patient method and interview, respectively 59 (46%) and 70 (55%) of HCPs referred the TB suspect to general health care. Only 11 (9%) referred the simulated patient to a TB care facility. Fifty-two (42%) of the HCPs identified suspected TB from a fictitious case described on paper; 34 (27%) were aware that free treatment was provided under the National Tuberculosis Programme (NTP). Knowledge about free NTP treatment predicted a higher rate of direct referrals to TB facilities (OR 5.80, 95%CI 1.88-19.62) and greater ability to identify suspected TB from a fictitious case on paper (OR 5.14, 95%CI 2.36-11.73). Pharmacies with Good Pharmacy Practice (GPP) certification were less likely to refer simulated patients to TB facilities than non-GPP pharmacies (OR 0.10, 95%CI ≤0.01-0.79). CONCLUSIONS: Nearly half of HCPs in private pharmacies do not refer TB suspects, possibly contributing to delays in diagnosis and treatment. Knowledge about free NTP treatment predicted better performance of HCPs.
Asunto(s)
Actitud del Personal de Salud , Servicios Comunitarios de Farmacia , Hospitales de Enfermedades Crónicas , Farmacéuticos/psicología , Sector Privado , Competencia Profesional , Derivación y Consulta , Tuberculosis/diagnóstico , Adulto , Antituberculosos/uso terapéutico , Concienciación , Diagnóstico Tardío , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Entrevistas como Asunto , Masculino , Persona de Mediana Edad , Análisis Multivariante , Programas Nacionales de Salud , Oportunidad Relativa , Simulación de Paciente , Valor Predictivo de las Pruebas , Pronóstico , Encuestas y Cuestionarios , Factores de Tiempo , Tuberculosis/tratamiento farmacológico , Tuberculosis/microbiología , Vietnam , Adulto JovenRESUMEN
Moxifloxacin (MFX) is a potential oral agent use in the treatment of multidrug-resistance tuberculosis (MDR-TB). Due to variability in pharmacokinetics and in vitro susceptibility of causative bacteria, therapeutic drug monitoring (TDM) of MFX is recommended. Conventional plasma sampling for TDM is facing logistical challenges, especially in limited resource areas, and dried blood spots (DBS) sampling may offer a chance to overcome this problem. The objective of this study was to develop a LC-MS/MS method for determination of MFX in dried blood spots (DBS) that is applicable for TDM. The influence of paper type, the hematocrit (Hct) and the blood volume per spot (V(b)) on the estimated blood volume in a disc (V(est)) was investigated. The extracts of 8mm diameter discs punched out from DBS were analyzed using liquid chromatography tandem mass spectrometry (LC-MS/MS) with cyanoimipramin as internal standard. The method was validated with respect to selectivity, linearity, accuracy, precision, sensitivity, recovery and stability. The effect of Hct and V(b) on LC-MS/MS analytical result was also investigated. The relationship between MFX concentrations in venous and finger prick DBS and those in plasma was clinically explored. V(est) was highly influenced by Hct while the effect of V(b) appeared to be different among paper types. Calibration curves were linear in the range of 0.05-6.00 mg/L with inter-day and intra-day precisions and biases of less than 11.1%. The recovery was 84.5, 85.1 and 92.6% in response to blood concentration of 0.15, 2.50 and 5.00 mg/L, respectively. A matrix effect of less than 11.9% was observed. MFX in DBS was stable for at least 4 weeks at room condition (temperature of 25°C and humidity of 50%). A large range of Hct value produced a significant analytical bias and it can be corrected with resulting DBS size. A good correlation between DBS and plasma concentrations was observed and comparable results between venous DBS and finger prick DBS was attained. This fully validated method is suitable for determination of MFX in dried blood spot and applicable for TDM.
Asunto(s)
Antituberculosos/sangre , Compuestos Aza/sangre , Cromatografía Liquida/métodos , Quinolinas/sangre , Espectrometría de Masas en Tándem/métodos , Tuberculosis/sangre , Antituberculosos/uso terapéutico , Compuestos Aza/uso terapéutico , Recolección de Muestras de Sangre , Volumen Sanguíneo , Monitoreo de Drogas , Estabilidad de Medicamentos , Fluoroquinolonas , Hematócrito , Humanos , Modelos Lineales , Moxifloxacino , Quinolinas/uso terapéutico , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Tuberculosis/tratamiento farmacológicoRESUMEN
Tuberculosis (TB) is a high-burden infectious disease, especially in low and middle-income countries. The efforts to eliminate this disease are challenged by the emergence of multidrug resistance and TB-HIV coinfection. The cumulative knowledge on pharmacokinetics/ pharmacodynamics of antituberculosis agents has recently encouraged therapeutic drug monitoring (TDM) in patient care. However, logistical problems related to conventional sampling limit the application of TDM in research-oriented institutions. Dried blood spot (DBS) compared with conventional venous blood sampling has the advantages of easier sampling, storage and transportation, thus enabling the application of TDM even in remote areas. In addition, DBS with its lower biohazardous risk can be safely performed in a high HIV prevalence area, which also tends to have a high TB burden. Another benefit of DBS sampling is that it requires a smaller blood volume than conventional sampling and is highly recommended for application in pediatric TB. A limitation of DBS is that additional considerations are required for analysis method development and validation. The accuracy of the DBS method is influenced by a number of factors that need to be thoroughly examined in method development and validation. Further, the agreement between DBS and plasma/serum concentrations is not always understood and further investigations are required.
Asunto(s)
Antituberculosos/uso terapéutico , Pruebas con Sangre Seca/métodos , Tuberculosis/tratamiento farmacológico , Antituberculosos/farmacocinética , Recolección de Muestras de Sangre/métodos , Niño , Monitoreo de Drogas/métodos , Infecciones por VIH/complicaciones , HumanosRESUMEN
BACKGROUND AND OBJECTIVES: The purpose of this study was to analyse the transfusion-related events recorded in a general university hospital. MATERIALS AND METHODS: The method we used was retrospective analysis of the data collected between 1999 and 2003. RESULTS: The incidence of transfusion reactions (n = 394) was 4.19 per 1000 blood products distributed: 59% (n = 231) were febrile non-haemolytic transfusion reactions; 22% (n = 88) were caused by allergy; 5% (n = 21) were caused by bacterial infection; and 14% (n = 54) were classified as other reactions. Platelet concentrates gave rise to a significantly greater number of reactions than erythrocyte concentrates and fresh-frozen plasma. Transfusion errors and near-miss events were also observed and were analysed separately. A series of transfusion-related events, such as haemosiderosis, metabolic disturbances or volume overload, were not reported. CONCLUSIONS: Our experience prompts us to propose a more comprehensive classification and codification of transfusion-related events.
Asunto(s)
Control de Formularios y Registros/normas , Hospitales Universitarios/normas , Gestión de Riesgos/normas , Reacción a la Transfusión , Infecciones Bacterianas/etiología , Transfusión de Componentes Sanguíneos/efectos adversos , Transfusión de Componentes Sanguíneos/estadística & datos numéricos , Clasificación , Recolección de Datos , Fiebre/etiología , Control de Formularios y Registros/métodos , Humanos , Hipersensibilidad/etiología , Isoanticuerpos , Errores Médicos/estadística & datos numéricos , Estudios Retrospectivos , Gestión de Riesgos/métodosRESUMEN
An investigation of the complex boundaries between adjacent lobes and segments in human cadaveric lungs was undertaken to provide information for the later construction of a three-dimensional model of the segmental and subsegmental anatomy of the human lungs. This was performed by analyzing scanned cross-sections of the lungs after color-coded gelatin had been injected into segmental bronchi and the lungs embedded in gelatin and frozen. The resulting images provided information regarding the pattern of boundaries present between both lobes and segments.
Asunto(s)
Pulmón/anatomía & histología , Cadáver , Gelatina/administración & dosificación , Humanos , Fijación del Tejido/métodosRESUMEN
The coracoclavicular ligaments vary widely in morphology and anatomic descriptions. Few authors have adequately described the coracoclavicular ligaments' anatomy, and a number of discrepancies exist in the anatomy literature. This study examines the complex anatomy of the coracoclavicular ligaments and their relationships to clinically important bony landmarks. The geometric dimensions of 24 coracoclavicular ligament specimens from fresh human cadaveric shoulders were examined and quantified with 13 different measurements. Particular attention was given to any inter-specimen anatomic variance. The coracoid insertions of the conoid ligaments displayed high variance, with 33% (8/24) being confluent with the lateral fibers of the superior transverse scapular ligament. A further 15% (3/24) presented an additional lateral fascicle. The distance from the lateral trapezoid ligament to the distal clavicle averaged 15.3 mm. Three distinct and previously unreported conoid ligament variants lend themselves to an anatomic classification (types I, II, and III). A safety margin of 15 mm is suggested for distal clavicle resection in incomplete acromioclavicular joint injuries to preserve the intact coracoclavicular ligament.
Asunto(s)
Articulación Acromioclavicular/anatomía & histología , Ligamentos Articulares/anatomía & histología , Anciano , Anciano de 80 o más Años , Cadáver , Disección , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sensibilidad y EspecificidadRESUMEN
The aim of this study is to describe a newly implemented haemovigilance system in a general university hospital. We present a series of short cases, highlighting particular aspects of the reports, and an overview of all reported incidents between 1999 and 2001. Incidents related to transfusion of blood products were reported by the clinicians using a standard preformatted form, giving a synopsis of the incident. After analysis, we distinguished, on the one hand, transfusion reactions, that are transfusions which engendered signs or symptoms, and, on the other hand, the incidents where management errors and/or dysfunctions took place. Over 3 years, 233 incidents were reported, corresponding to 4.2 events for 1000 blood products delivered. Of the 233, 198 (85%) were acute transfusion reactions and 35 (15%) were management errors and/or dysfunctions. Platelet units gave rise to statistically (P < 0.001) more transfusion reactions (10.7 per thousand ) than red blood cells (3.5 per thousand ) and fresh frozen plasma (0.8 per thousand ), particularly febrile nonhaemolytic transfusion reactions and allergic reactions. A detailed analysis of some of the transfusion incident reports revealed complex deviations and/or failures of the procedures in place in the hospital, allowing the implementation of corrective and preventive measures. Thus, the haemovigilance system in place in the 'Centre Hospitalier Universitaire Vaudois, CHUV' appears to constitute an excellent instrument for monitoring the security of blood transfusion.
Asunto(s)
Bancos de Sangre/normas , Hospitales Universitarios/normas , Gestión de Riesgos/normas , Reacción a la Transfusión , Anciano , Anciano de 80 o más Años , Incompatibilidad de Grupos Sanguíneos , Transfusión Sanguínea/normas , Niño , Femenino , Fiebre/etiología , Humanos , Masculino , Errores Médicos , Persona de Mediana Edad , Garantía de la Calidad de Atención de Salud , Gestión de Riesgos/estadística & datos numéricos , Suiza , Análisis de SistemasRESUMEN
OBJECTIVE: The investigation of pulmonary embolism using scintigraphic tomography requires a model of the internal architecture of the segments and subsegments in the human lung. Such a model has been developed by the segmentation and subsegmentation of an existing whole-body tissue-segmented phantom. MATERIALS AND METHODS: By using information from suitably windowed human axial CT scans, combined with the information gained from the injection of color-coded dyes into the segmental bronchi of human cadaveric lungs, the lobar and segmental boundaries were added to the existing phantom. Further refinements were added from reports in the literature regarding the predominant pattern of subsegmental bronchi in a series of human cadavers, enabling the creation of subsegmental boundaries. RESULTS: A digitized model of the segmental and subsegmental anatomy of the human lung was successfully created. External, or pleural, projections of the complex internal arrangement of the segments closely corresponded with the projections of the best available authorities on the subject. CONCLUSION: The model provides the opportunity to address several issues germane to scintigraphy and important for diagnosing pulmonary embolic disease. In particular, the model allows the manipulation of three-dimensional data sets to explore issues of importance to tomographic lung scanning.
Asunto(s)
Simulación por Computador , Procesamiento de Imagen Asistido por Computador , Pulmón/diagnóstico por imagen , Femenino , Humanos , Pulmón/anatomía & histología , Persona de Mediana Edad , Tomografía Computarizada por Rayos XRESUMEN
Bioassay-directed fractionation led to the isolation of 14 compounds, six of which possess antimalarial activity, from the dried leaves and stems of Rhaphidophora decursiva. Polysyphorin (1) and rhaphidecurperoxin (6) showed strong activities against Plasmodium falciparum. Rhaphidecursinol A (2), rhaphidecursinol B (3), grandisin (4), and epigrandisin (5) were less active against the same organism. Among the isolates, rhaphidecursinol A (2) and rhaphidecursinol B (3) were determined to be new neolignans, and rhaphidecurperoxin (6) is a new benzoperoxide. Known compounds isolated include polysyphorin (1), grandisin (4), epigrandisin (5), (+)-medioresinol, (-)-pinoresinol, (-)-syringaresinol, (+)-glaberide I, (+)-dehydrovomifoliol, (-)-liliolide, (-)-hydroxydihydrobovolide, and N-butylbenzamide, of which compound 1 appears worthy of further evaluation as an antimalarial agent. Structure elucidation and identification were accomplished by spectroscopic means including 1D and 2D NMR analyses.